Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0E3UM
|
||||
Former ID |
DNC004565
|
||||
Drug Name |
L-657925
|
||||
Synonyms |
L-657926
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Terminated | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C21H21ClFNO2
|
||||
Canonical SMILES |
C1CC(C2=C(C1)C3=C(N2CC4=CC=C(C=C4)Cl)C=CC(=C3)F)CC(=O)O
|
||||
InChI |
1S/C21H19ClFNO2/c22-15-6-4-13(5-7-15)12-24-19-9-8-16(23)11-18(19)17-3-1-2-14(21(17)24)10-20(25)26/h4-9,11,14H,1-3,10,12H2,(H,25,26)/t14-/m0/s1
|
||||
InChIKey |
LHJWQVJJSYPRIX-AWEZNQCLSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Thromboxane A2 receptor | Target Info | Inhibitor | [2] | |
KEGG Pathway | Calcium signaling pathway | ||||
Neuroactive ligand-receptor interaction | |||||
Platelet activation | |||||
Reactome | Prostanoid ligand receptors | ||||
G alpha (q) signalling events | |||||
G alpha (12/13) signalling events | |||||
Thromboxane signalling through TP receptor | |||||
WikiPathways | GPCRs, Class A Rhodopsin-like | ||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
Small Ligand GPCRs | |||||
Signal amplification | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000341) | ||||
REF 2 | J Med Chem. 1991 Apr;34(4):1511-4.Novel synthesis and biochemical properties of an [125I]-labeled photoaffinity probe for thromboxane A2/prostaglandin H2 receptors. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.